Seminars in Oncology
Volume 29, Issue 2 , Pages 168-182 , April 2002

Radiofrequency ablation of hepatic metastases

References 

  1. Weiss L, Grundmann E, Torhorst J, et al.  Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol. 1986;150:195–203
  2. Siperstein A, Garland A, Engle K, et al.  Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc. 2000;14:400–405
  3. Shumate CR. Hepatic resection for colorectal cancer metastases. In:  Curley SA editors. Liver Cancer. New York: NY, Springer-Verlag; 1998;p. 136–149
  4. Tuttle TM. Hepatectomy for noncolorectal metastases. In:  Curley SA editors. Liver Cancer. New York: NY, Springer-Verlag; 1998;p. 201–211
  5. Curley SA, Izzo F, Delrio P, et al.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1–8
  6. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Interv Radiol. 1997;14:313–324
  7. McGahan JP, Dodd GD. Radiofrequency ablation of the liver: Current status. AJR Am J Roentgenol. 2001;176:3–16
  8. Kemeny N, Huang Y, Cohen AM, et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039–2048
  9. Ellis LM, Chase J, Patt YZ, et al.  Hepatic arterial infusion chemotherapy for colorectal cancer metastasis to the liver. In:  Curley SA editors. Liver Cancer. New York, NY: Springer-Verlag; 1998;p. 150–172
  10. Siperstein A, Gitomirsky A. History and technological aspects of radiofrequency thermoablation. Cancer J. 2000;6(suppl 4):S293–S303
  11. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist. 2001;6:14–23
  12. Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: A critical review. Ann NY Acad Sci. 1980;335:180–205
  13. Goldberg SN. Radiofrequency tumor ablation: Principles and techniques. Eur J Ultrasound. 2001;13:129–147
  14. Goldberg SN, Gazelle GS, Halpern EF, et al.  Radiofrequency tissue ablation: Importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol. 1996;3:212–218
  15. Gazelle GS, Goldberg SN, Solbiati L, et al.  Tumor ablation with radio-frequency energy. Radiology. 2000;217:633–646
  16. Hager ED, Dziambor H, Hohmann D, et al.  Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer. Anticancer Res. 1999;19:3403–3408
  17. Miao Y, Ni Y, Yu J, et al.  A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol. 2000;35:438–444
  18. Livraghi T, Goldberg SN, Monti F, et al.  Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology. 1997;202:205–210
  19. Lorentzen T: A. cooled needle electrode for radiofrequency tissue ablation: Thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol. 1996;3:556–563
  20. Goldberg SN, Gazelle GS, Solbiati L, et al.  Radiofrequency tissue ablation: Increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3:636–644
  21. Solbiati L, Goldberg SN, Ierace T, et al.  Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology. 1997;205:367–373
  22. McGahan JP, Gu WZ, Brock JM, et al.  Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol. 1996;3:418–422
  23. Goldberg SN, Hahn PF, Tanabe KK, et al.  Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol. 1998;9:101–111
  24. Goldberg SN, Gazelle GS, Compton CC, et al.  Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation. Cancer. 2000;88:2452–2463
  25. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: Techniques, indications, imaging findings, and clinical results. Abdom Imaging. 2001;26:345–360
  26. Bilchik AJ, Wood TF, Allegra D, et al.  Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: A proposed algorithm. Arch Surg. 2000;135:657–662
  27. Pearson AS, Izzo F, Fleming RY, et al.  Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599
  28. Scott DJ, Young WN, Watumull LM, et al.  Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation. Surg Endosc. 2001;15:135–140
  29. Chinn SB, Lee FT, Kennedy GD, et al.  Effect of vascular occlusion on radiofrequency ablation of the liver: Results in a porcine model. AJR Am J Roentgenol. 2001;176:789–795
  30. Curley SA, Izzo F, Ellis LM, et al.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381–391
  31. Aschoff AJ, Merkle EM, Wong V, et al.  How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver?. J Magn Reson Imaging. 2001;13:57–63
  32. Patterson EJ, Scudamore CH, Owen DA, et al.  Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size. Ann Surg. 1998;227:559–565
  33. Rossi S, Garbagnati F, De Francesco I, et al.  Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori. 1999;85:128–132
  34. Berber E, Foroutani A, Garland AM, et al.  Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc. 2000;14:799–804
  35. Solbiati L, Goldberg SN, Ierace T, et al.  Radio-frequency ablation of hepatic metastases: Postprocedural assessment with a US Microbubble contrast agent—Early experience. Radiology. 1999;211:643–649
  36. Cha CH, Lee FT, Gurney JM, et al.  CT versus sonograpy for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol. 2000;175:705–711
  37. Solbiati L, Ierace T, Tonolini M, et al.  Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13:149–158
  38. Chopra S, Dodd GD, Chintapalli KN, et al.  Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: Spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol. 2001;177:381–387
  39. Rossi S, Di Stasi M, Buscarini E, et al.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996;167:759–768
  40. Rossi S, Buscarini E, Garbagnati F, et al.  Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998;170:1015–1022
  41. Solbiati L, Ierace T, Goldberg SN, et al.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients. Radiology. 1997;202:195–203
  42. Siperstein A, Garland A, Engle K, et al.  Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol. 2000;7:106–113
  43. Wood TF, Rose DM, Chung M, et al.  Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol. 2000;7:593–600
  44. Bowles BJ, Machi J, Limm WM, et al.  Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg. 2001;136:864–869
  45. de Baere T, Elias D, Dromain C, et al.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol. 2000;175:1619–1625
  46. Livraghi T. Guidelines for treatment of liver cancer. Eur J Ultrasound. 2001;13:167–176
  47. Abraham J, Fojo T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer. Ann Intern Med. 2000;133:312–313
  48. Siperstein AE, Rogers SJ, Hansen PD, et al.  Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery. 1997;122:1147–1154
  49. Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg. 2001;25:693–696
  50. Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res. 2001;95:8–12
  51. Elias D, Debaere T, Muttillo I, et al.  Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol. 1998;67:190–191
  52. Elias D, Goharin A, El Otmany A, et al.  Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol. 2000;26:763–769
  53. Jiao LR, Hansen PD, Havlik R, et al.  Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg. 1999;177:303–306
  54. Kainuma O, Asano T, Aoyama H, et al.  Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology. 1999;46:1071–1077

☆ Supported in part by NIH T32 CA09599-13 (A.P.) and The Jon and Susie Hall Fund for Colon Cancer Research (L.M.E.).

☆☆ Address reprint requests to Lee M. Ellis, MD, Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 444, Houston, TX 77030-4009.

PII: S0093-7754(02)50138-X

doi: 10.1053/sonc.2002.31673

Seminars in Oncology
Volume 29, Issue 2 , Pages 168-182 , April 2002

Article Tools

* Image Usage & Resolution